Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy
Clinical trial NCT06758037 · RECRUITING
Trial details
- NCT number
- NCT06758037
- Sponsor
- First Affiliated Hospital of Ningbo University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2026-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.